Log in to search using one of your social media accounts:

 

CDx & #039;s WATS3D Highly Effective in Real World Setting
CDx Diagnostics said results from a recent multicenter prospective trial show the use of its WATS3D test increases the detection of both Barrett’s esophagus and esophageal dysplasia by more than 80%. The results were published in the latest issue of United European Gastroenterology Journal and featured in the American Society for Gastrointestinal Endoscopy (ASGE’s) Scope Tech Talk Video Series. The trial was conducted at 25 community-based gastrointestinal (GI) centers across the U.S. In the study, 4,203 patients were tested for esophageal disease. The findings show that with the inclusion of WATS3D overal...
Source: MDDI - March 26, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Design News Source Type: news

Bacteria may promote pancreatic cancer by suppressing the immune system
(American Association for Cancer Research) Bacterial load was significantly higher in pancreatic tumor samples from patients with pancreatic ductal adenocarcinoma compared with pancreatic tissue from normal individuals, and in studies using mice, eliminating certain 'bad' bacteria slowed the growth of pancreatic cancer, reversed immune suppression, and upregulated the immune checkpoint protein PD1. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 22, 2018 Category: Cancer & Oncology Source Type: news

Can Microbubbles Deliver Gene Therapy?
An Italian diagnostic imaging company is teaming with a Chicago startup to study whether microbubbles can deliver personalized gene therapy to treat high LDL cholesterol. Microbubble technology, combined with contrast-enhanced ultrasound, has been used diagnostically for years and more recently has inspired research for treatment of disease. Milan-based Bracco Imaging, S.p.A. is working with Steven Feinstein, a professor of medicine at Rush University Medical Center and president of SonoGene, LLC to pursue the treatment possibilities further. A CEUS researcher, Feinstein is also co-president of the  International Cont...
Source: MDDI - February 9, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: R & D Source Type: news

Incidence of Lung Adenocarcinoma in Never Smokers Incidence of Lung Adenocarcinoma in Never Smokers
Despite a decrease in exposure to secondhand smoke, never smokers continue to be at risk for lung cancer.Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 23, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus
(Case Western Reserve University) Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise for preventing deaths from esophageal adenocarcinoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 17, 2018 Category: Cancer & Oncology Source Type: news

Keratin 17: A Biomarker in Endocervical Glandular Neoplasia Keratin 17: A Biomarker in Endocervical Glandular Neoplasia
This study ascertained that expression of keratin 17 is associated with decreased survival of patients with endocervical adenocarcinoma.American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 15, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer
Colorectal cancers comprise a complex mixture of malignant cells, nontransformed cells, and microorganisms. Fusobacterium nucleatum is among the most prevalent bacterial species in colorectal cancer tissues. Here we show that colonization of human colorectal cancers with Fusobacterium and its associated microbiome—including Bacteroides, Selenomonas, and Prevotella species—is maintained in distal metastases, demonstrating microbiome stability between paired primary and metastatic tumors. In situ hybridization analysis revealed that Fusobacterium is predominantly associated with cancer cells in the metastatic les...
Source: ScienceNOW - December 14, 2017 Category: Science Authors: Bullman, S., Pedamallu, C. S., Sicinska, E., Clancy, T. E., Zhang, X., Cai, D., Neuberg, D., Huang, K., Guevara, F., Nelson, T., Chipashvili, O., Hagan, T., Walker, M., Ramachandran, A., Diosdado, B., Serna, G., Mulet, N., Landolfi, S., Ramon y Cajal, S., Tags: Medicine, Diseases reports Source Type: news

FDA approves first biosimilar for the treatment of certain breast and stomach cancers
The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+). Ogivri is the first biosimilar approved in the U.S. for the treatment of breast cancer or stomach cancer and the second biosimilar approved in the U.S. for the treatment of cancer. (Source: World Pharma News)
Source: World Pharma News - December 1, 2017 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils
Bone marrow–derived myeloid cells can accumulate within tumors and foster cancer outgrowth. Local immune-neoplastic interactions have been intensively investigated, but the contribution of the systemic host environment to tumor growth remains poorly understood. Here, we show in mice and cancer patients (n = 70) that lung adenocarcinomas increase bone stromal activity in the absence of bone metastasis. Animal studies reveal that the cancer-induced bone phenotype involves bone-resident osteocalcin-expressing (Ocn+) osteoblastic cells. These cells promote cancer by remotely supplying a distinct subset of tumor-infiltrat...
Source: ScienceNOW - November 30, 2017 Category: Science Authors: Engblom, C., Pfirschke, C., Zilionis, R., Da Silva Martins, J., Bos, S. A., Courties, G., Rickelt, S., Severe, N., Baryawno, N., Faget, J., Savova, V., Zemmour, D., Kline, J., Siwicki, M., Garris, C., Pucci, F., Liao, H.-W., Lin, Y.-J., Newton, A., Yaghi, Tags: Medicine, Diseases r-articles Source Type: news

Vargatef ® (nintedanib*) approved in the EU for lung cancer patients with advanced adenocarcinoma after first-line chemotherapy
Vargatef ® (nintedanib*) approved in the EU for lung cancer patients with advanced adenocarcinoma after first-line chemotherapy (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news

NICE recommends VARGATEF ® (nintedanib*) in combination with docetaxel as an option for patients with non-small cell lung cancer of adenocarcinoma histology within its licensed indication
NICE recommends VARGATEF ® (nintedanib*) in combination with docetaxel as an option for patients with non-small cell lung cancer of adenocarcinoma histology within its licensed indication (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news

VARGATEF ® plus docetaxel significantly reduced tumour burden in lung cancer patients with advanced adenocarcinoma compared to docetaxel alone
VARGATEF ® plus docetaxel significantly reduced tumour burden in lung cancer patients with advanced adenocarcinoma compared to docetaxel alone (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news

Biomarker Panel to Identify Early-Stage Pancreatic Cancer Biomarker Panel to Identify Early-Stage Pancreatic Cancer
A biomarker panel may add significantly to the predictive power of CA 19-9 to detect early-stage pancreatic ductal adenocarcinoma.Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 27, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Wider sampling of tumor tissues may guide drug choice, improve outcomes
This study challenges current guidelines and supports evaluation of metastatic lesions and circulating tumor DNA. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 15, 2017 Category: Cancer & Oncology Source Type: news

Gastroesophageal Junction Adenocarcinoma
Title: Gastroesophageal Junction AdenocarcinomaCategory: Diseases and ConditionsCreated: 11/7/2017 12:00:00 AMLast Editorial Review: 11/7/2017 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 7, 2017 Category: Cancer & Oncology Source Type: news

Many EEs on pancreatic ductal adenocarcinoma not high quality
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2017 Category: Drugs & Pharmacology Source Type: news

Biomarkers for Selecting Lung Adenocarcinoma Therapy Biomarkers for Selecting Lung Adenocarcinoma Therapy
Review recent advances in diagnosis and treatment of advanced nonsquamous NSCLC.Journal of Oncology Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 23, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Electronic Nose Promising for Barrett's Esophagus Detection
(MedPage Today) -- Test may facilitate surveillance for esophageal adenocarcinoma (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - October 17, 2017 Category: Gastroenterology Source Type: news

Does Adjuvant Chemo Improve Survival in Gastroesophageal Cancer? Does Adjuvant Chemo Improve Survival in Gastroesophageal Cancer?
n patients with locally advanced gastroesophageal adenocarcinoma treated with preoperative chemoradiation and resection, adjuvant chemotherapy is associated with improved overall survival.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 2, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Adjuvant Chemo Beneficial in Advanced Gastroesophageal CA
Improved overall survival for patients with locally - advanced gastroesophageal adenocarcinoma (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 26, 2017 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pharmacy, Radiology, Surgery, Journal, Source Type: news

Merck ’s Keytruda receives accelerated FDA approval for GEJ adenocarcinoma
Merck ’s Keytruda (pembrolizumab) has received approval from the US Food and Drug Administration (FDA) to treat patients with recurrent locally advanced or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 24, 2017 Category: Pharmaceuticals Source Type: news

The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizing FAK
Large-scale, genome-wide studies report that RNA binding proteins are altered in cancers, but it is unclear how these proteins control tumor progression. We found that the RNA-editing protein ADAR (adenosine deaminase acting on double-stranded RNA) acted as a facilitator of lung adenocarcinoma (LUAD) progression through its ability to stabilize transcripts encoding focal adhesion kinase (FAK). In samples from 802 stage I LUAD patients, increased abundance of ADAR at both the mRNA and protein level correlated with tumor recurrence. Knocking down ADAR in LUAD cells suppressed their mesenchymal properties, migration, and inva...
Source: Signal Transduction Knowledge Environment - September 19, 2017 Category: Science Authors: Amin, E. M., Liu, Y., Deng, S., Tan, K. S., Chudgar, N., Mayo, M. W., Sanchez-Vega, F., Adusumilli, P. S., Schultz, N., Jones, D. R. Tags: STKE Research Articles Source Type: news

Highlight: RNA-binding proteins in cancer
ADAR promotes lung adenocarcinoma migration and invasion through stabilization of FAK. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - September 19, 2017 Category: Science Authors: Yaffe, M. B. Tags: STKE Editors ' Choice Source Type: news

Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Growing evidence suggests that microbes can influence the efficacy of cancer therapies. By studying colon cancer models, we found that bacteria can metabolize the chemotherapeutic drug gemcitabine (2',2'-difluorodeoxycytidine) into its inactive form, 2',2'-difluorodeoxyuridine. Metabolism was dependent on the expression of a long isoform of the bacterial enzyme cytidine deaminase (CDDL), seen primarily in Gammaproteobacteria. In a colon cancer mouse model, gemcitabine resistance was induced by intratumor Gammaproteobacteria, dependent on bacterial CDDL expression, and abrogated by cotreatment with the antibiotic ciprofloxa...
Source: ScienceNOW - September 14, 2017 Category: Science Authors: Geller, L. T., Barzily-Rokni, M., Danino, T., Jonas, O. H., Shental, N., Nejman, D., Gavert, N., Zwang, Y., Cooper, Z. A., Shee, K., Thaiss, C. A., Reuben, A., Livny, J., Avraham, R., Frederick, D. T., Ligorio, M., Chatman, K., Johnston, S. E., Mosher, C. Tags: Medicine, Diseases reports Source Type: news

CSA Medical wins another FDA expansion for TruFreeze cryotherapy
Endoscopic cryo-ablation company CSA Medical said today it won expanded FDA 510(k) clearance for its TruFreeze spray cryotherapy system, now cleared for use on patients with Barrett’s esophagus with low grade dysplasia. With the clearance, the device is now approved for both low and high grade dysplasia as well as malignancies, the Boston-based company said. “Over the past few years, studies have underscored the potential risk for Barrett’s esophagus with low grade dysplasia to progress to esophageal adenocarcinoma. Intervening at this level of dysplasia has become common practice and is recogni...
Source: Mass Device - August 31, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Otolaryngology Ear, Nose & Throat Regulatory/Compliance CSA Medical Inc. Source Type: news

PET-assessed Tumor Response Does Not Predict Gastric Adenocarcinoma Outcomes PET-assessed Tumor Response Does Not Predict Gastric Adenocarcinoma Outcomes
Post-treatment/preoperative tumor response, as measured on positron emission tomography (PET), does not predict outcomes in patients with gastric and gastroesophageal junction (GEJ) adenocarcinoma, according to a database review.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - August 17, 2017 Category: Radiology Tags: Radiology News Source Type: news

Men more likely the target for esophageal cancer
About 17,000 people in the U.S. are diagnosed with esophageal cancer each year – more than 13,000 are men. It affects the esophagus – a long tube that sends food and liquids from your throat to your stomach. Esophageal cancer can make it difficult to eat and affect your quality of life. Here are ways how to reduce your risk of the disease. Age, gender, race, and weight a re risk factors – The most common type of esophageal cancer is called adenocarcinoma. It begins in the lower part of the… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 14, 2017 Category: American Health Authors: Dr. Ghulam Abbas Source Type: news

Men more likely the target for esophageal cancer
About 17,000 people in the U.S. are diagnosed with esophageal cancer each year – more than 13,000 are men. It affects the esophagus – a long tube that sends food and liquids from your throat to your stomach. Esophageal cancer can make it difficult to eat and affect your quality of life. Here are ways how to reduce your risk of the disease. Age, gender, race, and weight a re risk factors – The most common type of esophageal cancer is called adenocarcinoma. It begins in the lower part of the… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 14, 2017 Category: Biotechnology Authors: Dr. Ghulam Abbas Source Type: news

Novel Agent S-1 Has Similar Efficacy to 5-FU in Certain Gastric Cancers
Results of a phase III trial suggest that the combination of the contemporary oral fluoropyrimidine S-1 and cisplatin offers similar efficacy to 5-flourouracil and cisplatin in patients with chemotherapy-naive diffuse type adenocarcinoma of the gastroesophageal junction or stomach. (Source: CancerNetwork)
Source: CancerNetwork - August 10, 2017 Category: Cancer & Oncology Authors: Dave Levitan Tags: Gastrointestinal Cancer News Source Type: news

Researchers identify prognostic indicators of survival following pancreatic tumor removal
(Mary Ann Liebert, Inc./Genetic Engineering News) A new study of patients who underwent curative surgical removal of a pancreatic ductal adenocarcinoma showed that two of the nine preoperative factors analyzed were strongly predictive of poor prognosis regardless of the tumor stage. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 10, 2017 Category: Cancer & Oncology Source Type: news

Mechanisms ID ’ d for Curcumin Resensitization of Cancer Cells
Compound helps turn off pathways linked to chemoresistance in pancreatic ductal adenocarcinoma (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 2, 2017 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Journal, Source Type: news

Medical News Today: Adenocarcinoma: Types, diagnosis, and treatment
Adenocarcinoma is a type of cancer that affects the glands. Learn about the different types of adenocarcinoma, their symptoms, treatments, and outlook. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 2, 2017 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

A Braf kinase-inactive mutant induces lung adenocarcinoma
(Centro Nacional de Investigaciones Oncol ó gicas (CNIO)) The initiating oncogenic event in half of human lung adenocarcinomas is still unknown, a fact that complicates the development of selective targeted therapies. Researchers at the CNIO have demonstrated that the expression of an endogenous Braf kinase-inactive isoform in mice triggers lung adenocarcinoma in vivo, indicating that BRAF-inactivating mutations are initiating events in lung oncogenesis. The paper indicates that the signal intensity of the MAPK pathway is a critical determinant in tumor development. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 2, 2017 Category: Cancer & Oncology Source Type: news

Halozyme initiates Phase Ib/II oncology combination trial
US-based biotechnology firm Halozyme Therapeutics has initiated a Phase Ib/II clinical trial of PEGPH20 and atezolizumab (Tecentriq) combination to treat metastatic pancreatic ductal adenocarcinoma. (Source: Drug Development Technology)
Source: Drug Development Technology - July 16, 2017 Category: Pharmaceuticals Source Type: news

As One Type of Esophageal Cancer Declines, Another Rises Sharply As One Type of Esophageal Cancer Declines, Another Rises Sharply
Even as the incidence of esophageal squamous cell carcinoma (ESCC) continues to decline in most countries, the incidence of esophageal adenocarcinoma (EAC) is rising to at least a comparable extent, according to a new study of 12 nations.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 28, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Small-Bowel Adenocarcinoma Shows Unique Genomic Profile Small-Bowel Adenocarcinoma Shows Unique Genomic Profile
Genomic profiling demonstrates that small-bowel adenocarcinoma (SBA) is significantly different from colorectal cancer and gastric carcinoma, according to a large study.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - June 22, 2017 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Docetaxel-Based Triplet New Standard in Gastric Cancer
Perioperative chemotherapy with a docetaxel-based triplet should be considered the new standard of care for resectable gastric or GEJ adenocarcinoma. (Source: CancerNetwork)
Source: CancerNetwork - June 21, 2017 Category: Cancer & Oncology Authors: Mark L. Fuerst Tags: Gastrointestinal Cancer News Source Type: news

PEGPH20 Could Improve Metastatic Pancreatic Cancer Outcomes
Adding PEGPH20 to nab-paclitaxel and gemcitabine improved progression-free survival in patients with untreated, metastatic pancreatic ductal adenocarcinoma. (Source: CancerNetwork)
Source: CancerNetwork - June 16, 2017 Category: Cancer & Oncology Authors: Dave Levitan Tags: Gastrointestinal Cancer News Pancreatic Cancer Source Type: news

Transcriptional activation of RagD GTPase controls mTORC1 and promotes cancer growth
The mechanistic target of rapamycin complex 1 (mTORC1) is recruited to the lysosome by Rag guanosine triphosphatases (GTPases) and regulates anabolic pathways in response to nutrients. We found that MiT/TFE transcription factors—master regulators of lysosomal and melanosomal biogenesis and autophagy—control mTORC1 lysosomal recruitment and activity by directly regulating the expression of RagD. In mice, this mechanism mediated adaptation to food availability after starvation and physical exercise and played an important role in cancer growth. Up-regulation of MiT/TFE genes in cells and tissues from patients and...
Source: ScienceNOW - June 15, 2017 Category: Science Authors: Di Malta, C., Siciliano, D., Calcagni, A., Monfregola, J., Punzi, S., Pastore, N., Eastes, A. N., Davis, O., De Cegli, R., Zampelli, A., Di Giovannantonio, L. G., Nusco, E., Platt, N., Guida, A., Ogmundsdottir, M. H., Lanfrancone, L., Perera, R. M., Zoncu Tags: Genetics reports Source Type: news

Filtered Cigarettes May Up Rates of Lung Adenocarcinoma
Design of cigarette filters with ventilation implicated in rising rates (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 23, 2017 Category: Respiratory Medicine Tags: Family Medicine, Gynecology, Internal Medicine, Nursing, Oncology, Pathology, Pulmonology, Journal, Source Type: news

FDA Grants Priority Review to Merck ’s Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab) for Treatment of Recurrent or Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Dateline City: KENILWORTH, N.J. Data Supporting Application to Be Presented at 2017 ASCO Annual MeetingKENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab), the company ’s anti-PD-1 therapy, seeking approval for treatment of patients with recurrent or advanced gastric or gastroesophageal junction adenocarcinoma who have already received two or more lines of chemotherapy....
Source: Merck.com - Product News - May 23, 2017 Category: Drugs & Pharmacology Tags: Oncology Newsroom Prescription Medicine News Corporate News Latest News #Merck #MRK $MRK cancer Keytruda MSD NYSE:MRK Source Type: news

Review Suggests FDA Should Tighten Regulations on Filtered Cigarettes
Evidence suggests that the inclusion of ventilation in cigarette filters has contributed to the increased rate of lung adenocarcinoma among smokers. (Source: CancerNetwork)
Source: CancerNetwork - May 22, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Lung Cancer News Source Type: news

The Hole Story: Ventilated Filters Make Smoking More Deadly The Hole Story: Ventilated Filters Make Smoking More Deadly
Ventilation holes in filters -- now found in nearly every brand of cigarette -- make smoking even more deadly and are associated with a steep rise in lung adenocarcinoma.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 22, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Use of 'light' cigarettes linked to rise in lung adenocarcinoma
Study shows so-called " light " cigarettes do not benefit health and may contribute to the increased risk of lung adenocarcinoma, a form of lung cancer. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 22, 2017 Category: Consumer Health News Source Type: news

'Light' cigarettes make smokers more prone to lung cancer
A 'clear relationship' was seen between rising rates of adenocarcinoma and greater demand for light cigarettes, according to researchers from Ohio State University. (Source: the Mail online | Health)
Source: the Mail online | Health - May 22, 2017 Category: Consumer Health News Source Type: news

Rise in lung adenocarcinoma linked to 'light' cigarette use
(Ohio State University Wexner Medical Center) A new study shows that so-called 'light' cigarettes have no health benefits to smokers and have likely contributed to the rise of a certain form of lung cancer that occurs deep in the lungs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 22, 2017 Category: International Medicine & Public Health Source Type: news

Biologists identify key step in lung cancer evolution
Biologists have identified a major switch that occurs as lung adenomas transition to more aggressive adenocarcinomas -- and that blocking this switch prevents the transition. The findings suggest drugs interfering with this switch could be useful in treating early-stage lung cancers. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 10, 2017 Category: Science Source Type: news

Biologists identify key step in lung cancer evolution
(Massachusetts Institute of Technology) MIT biologists have identified a major switch that occurs as lung adenomas transition to more aggressive adenocarcinomas -- and that blocking this switch prevents the transition. The findings suggest drugs interfering with this switch could be useful in treating early-stage lung cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 10, 2017 Category: Cancer & Oncology Source Type: news

This molecule stops pancreatic cancer cells from spreading
This micrograph shows pancreatic ductal adenocarcinoma (the most common type of pancreatic cancer). [Image by KGH – Own work, CC BY-SA 3.0]Wake Forest Baptist Medical Center scientists have identified molecules that could be the next therapeutic solution for pancreatic cancer. Pancreatic cancer is one of the most lethal forms of cancer. About 53,670 people are expected to be diagnosed with pancreatic cancer this year with 43,090 dying from it, according to the American Cancer Society. The lifetime risk of developing pancreatic cancer is about 1 in 65 but can be reduced by knowing the risk factors. The risk ...
Source: Mass Device - April 19, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Biotech Oncology Cancer pancreatic cancer Tianjin Medical University University of Texas Wake Forest Baptist Medical Center Source Type: news

Trastuzumab Disappoints in HER2-Positive Gastroesophageal Cancer Trastuzumab Disappoints in HER2-Positive Gastroesophageal Cancer
The HER2-targeted monoclonal antibody trastuzumab coupled with the tubulin inhibitor emtansine is no better than taxane against previously treated, HER2-positive advanced gastric or gastroesophageal junction adenocarcinoma.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 17, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news